Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...

Federal judges in Texas and Connecticut on Thursday ruled against arguments challenging the constitutionality of the Medicare ...

Little-known provisions in the Big Beautiful Bill lobbied by industry will cost Medicare billions in missed savings.

Boehringer Ingelheim Pharmaceuticals Inc. failed to prove to an appeals court that a Biden-era drug pricing program aimed at ...

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.

Medicare drug price negotiation is still relatively new. Until the 2022 passage of the Inflation Reduction Act, Medicare part D, which covers more than 50 million seniors, didn't have the ...

Medicare Drug Price Negotiations Target of Trump Executive Action But will potential pharmaceutical tariffs nullify lower prescription costs? Plus Biden knocks DOGE Social Security job cuts.

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to ...

In the wide-ranging order, Trump directed Health and Human Services Secretary Robert F. Kennedy Jr. to work with Congress to modify a piece of the Medicare drug price negotiation rules, which ...

Medicare drug price negotiation is still relatively new. Until the 2022 passage of the Inflation Reduction Act, Medicare part D, which covers more than 50 million seniors, didn't have the ...